Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
57,301,030
-
Share change
-
+2,772,598
-
Total reported value
-
$1,918,395,943
-
Put/Call ratio
-
16%
-
Price per share
-
$33.48
-
Number of holders
-
162
-
Value change
-
+$53,781,587
-
Number of buys
-
82
-
Number of sells
-
97
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2018
As of 31 Dec 2018,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,301,030 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, BlackRock Inc., BAILLIE GIFFORD & CO, Capital World Investors, Darsana Capital Partners LP, PRICE T ROWE ASSOCIATES INC /MD/, CREDIT SUISSE AG/, STATE STREET CORP, and TimesSquare Capital Management, LLC.
This page lists
162
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.